Principal Financial Group’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-5,265
| Closed | -$241K | – | 2321 |
|
|
2024
Q2 | $241K | Sell |
5,265
-1,798
| -25% | -$82.2K | ﹤0.01% | 2105 |
|
|
2024
Q1 | $468K | Buy |
7,063
+574
| +9% | +$38K | ﹤0.01% | 1997 |
|
|
2023
Q4 | $258K | Sell |
6,489
-23
| -0.4% | -$914 | ﹤0.01% | 2102 |
|
|
2023
Q3 | $208K | Sell |
6,512
-100
| -2% | -$3.19K | ﹤0.01% | 2158 |
|
|
2023
Q2 | $266K | Buy |
6,612
+735
| +13% | +$29.5K | ﹤0.01% | 2106 |
|
|
2023
Q1 | $251K | Sell |
5,877
-400
| -6% | -$17.1K | ﹤0.01% | 2128 |
|
|
2022
Q4 | $301K | Buy |
+6,277
| New | +$301K | ﹤0.01% | 2095 |
|
|
2021
Q1 | – | Sell |
-3,140
| Closed | -$221K | – | 2490 |
|
|
2020
Q4 | $221K | Buy |
+3,140
| New | +$221K | ﹤0.01% | 2293 |
|